HCSG Quote, Financials, Valuation and Earnings

Encompass Health has a net margin of 3.85% compared to Healthcare Services Group's net margin of 10.41%. Healthcare Services Group's return on equity of 8.45% beat Encompass Health's return on equity of 18.4%.

Healthcare Services Group has a consensus price target of $15.00, signalling upside risk potential of 5.56%. On the other hand Encompass Health has an analysts' consensus of $129.18 which suggests that it could grow by 10.42%. Given that Encompass Health has higher upside potential than Healthcare Services Group, analysts believe Encompass Health is more attractive than Healthcare Services Group.

Healthcare Services Group has a beta of 0.549, which suggesting that the stock is 45.143% less volatile than S&P 500. In comparison Encompass Health has a beta of 0.930, suggesting its less volatile than the S&P 500 by 7.02%.

Healthcare Services Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Encompass Health offers a yield of 0.56% to investors and pays a quarterly dividend of $0.17 per share. Healthcare Services Group pays -- of its earnings as a dividend. Encompass Health pays out 13.78% of its earnings as a dividend. Encompass Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Healthcare Services Group quarterly revenues are $447.7M, which are smaller than Encompass Health quarterly revenues of $1.5B. Healthcare Services Group's net income of $17.2M is lower than Encompass Health's net income of $151.5M. Notably, Healthcare Services Group's price-to-earnings ratio is 25.38x while Encompass Health's PE ratio is 24.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Services Group is 0.60x versus 2.17x for Encompass Health. Usually stocks with elevated PS ratios are considered overvalued.

Kindly MD has a net margin of 3.85% compared to Healthcare Services Group's net margin of -156.54%. Healthcare Services Group's return on equity of 8.45% beat Kindly MD's return on equity of -201.03%.

Healthcare Services Group has a consensus price target of $15.00, signalling upside risk potential of 5.56%. On the other hand Kindly MD has an analysts' consensus of -- which suggests that it could fall by --. Given that Healthcare Services Group has higher upside potential than Kindly MD, analysts believe Healthcare Services Group is more attractive than Kindly MD.

Healthcare Services Group has a beta of 0.549, which suggesting that the stock is 45.143% less volatile than S&P 500. In comparison Kindly MD has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Healthcare Services Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kindly MD offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Healthcare Services Group pays -- of its earnings as a dividend. Kindly MD pays out -- of its earnings as a dividend.

Healthcare Services Group quarterly revenues are $447.7M, which are larger than Kindly MD quarterly revenues of $647.9K. Healthcare Services Group's net income of $17.2M is higher than Kindly MD's net income of -$1M. Notably, Healthcare Services Group's price-to-earnings ratio is 25.38x while Kindly MD's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Services Group is 0.60x versus 3.95x for Kindly MD. Usually stocks with elevated PS ratios are considered overvalued.

Surgery Partners has a net margin of 3.85% compared to Healthcare Services Group's net margin of -12.55%. Healthcare Services Group's return on equity of 8.45% beat Surgery Partners's return on equity of -4.8%.

Healthcare Services Group has a consensus price target of $15.00, signalling upside risk potential of 5.56%. On the other hand Surgery Partners has an analysts' consensus of $31.36 which suggests that it could grow by 42.89%. Given that Surgery Partners has higher upside potential than Healthcare Services Group, analysts believe Surgery Partners is more attractive than Healthcare Services Group.

Healthcare Services Group has a beta of 0.549, which suggesting that the stock is 45.143% less volatile than S&P 500. In comparison Surgery Partners has a beta of 1.961, suggesting its more volatile than the S&P 500 by 96.073%.

Healthcare Services Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Surgery Partners offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Healthcare Services Group pays -- of its earnings as a dividend. Surgery Partners pays out -- of its earnings as a dividend.

Healthcare Services Group quarterly revenues are $447.7M, which are smaller than Surgery Partners quarterly revenues of $864.4M. Healthcare Services Group's net income of $17.2M is higher than Surgery Partners's net income of -$108.5M. Notably, Healthcare Services Group's price-to-earnings ratio is 25.38x while Surgery Partners's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Services Group is 0.60x versus 0.89x for Surgery Partners. Usually stocks with elevated PS ratios are considered overvalued.

The Oncology Institute has a net margin of 3.85% compared to Healthcare Services Group's net margin of -13.15%. Healthcare Services Group's return on equity of 8.45% beat The Oncology Institute's return on equity of -220.55%.

Healthcare Services Group has a consensus price target of $15.00, signalling upside risk potential of 5.56%. On the other hand The Oncology Institute has an analysts' consensus of -- which suggests that it could fall by -19.36%. Given that Healthcare Services Group has higher upside potential than The Oncology Institute, analysts believe Healthcare Services Group is more attractive than The Oncology Institute.

Healthcare Services Group has a beta of 0.549, which suggesting that the stock is 45.143% less volatile than S&P 500. In comparison The Oncology Institute has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Healthcare Services Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Oncology Institute offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Healthcare Services Group pays -- of its earnings as a dividend. The Oncology Institute pays out -- of its earnings as a dividend.

Healthcare Services Group quarterly revenues are $447.7M, which are larger than The Oncology Institute quarterly revenues of $100.3M. Healthcare Services Group's net income of $17.2M is higher than The Oncology Institute's net income of -$13.2M. Notably, Healthcare Services Group's price-to-earnings ratio is 25.38x while The Oncology Institute's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Healthcare Services Group is 0.60x versus 0.47x for The Oncology Institute. Usually stocks with elevated PS ratios are considered overvalued.